MicroRNA-361-5p facilitates cervical cancer progression through mediation of epithelial-to-mesenchymal transition

Wu, Xiaomei; Xi, Xiaowei; Yan, Qin; Zhang, Zhenbo; Cai, Bin; Lu, Wen; Wan, Xiaoping
December 2013
Medical Oncology;Dec2013, Vol. 30 Issue 4, p1
Academic Journal
No abstract available.


Related Articles

  • The key role of astrocyte elevated gene-1 in CCR6-induced EMT in cervical cancer. Zhang, Juan; Zhu, Dingjun; Lv, Qiongying; Yi, Yuexiong; Li, Fei; Zhang, Wei // Tumor Biology;Dec2015, Vol. 36 Issue 12, p9763 

    In recent years, astrocyte elevated gene-1 (AEG-1) has been recommended as an important mediator that is involved in the epithelial-to-mesenchymal transition (EMT) process. However, the mechanisms underlying the chemokine (C-C motif) ligand 20 (CCL20)/chemokine (C-C motif) receptor 6...

  • MicroRNA-30c inhibits human breast tumour chemotherapy resistance by regulating TWF1 and IL-11. Bockhorn, Jessica; Dalton, Rachel; Nwachukwu, Chika; Huang, Simo; Prat, Aleix; Yee, Kathy; Chang, Ya-Fang; Huo, Dezheng; Wen, Yujia; Swanson, Kaitlin E.; Qiu, Tyler; Lu, Jun; Young Park, Seo; Eileen Dolan, M.; Perou, Charles M.; Olopade, Olufunmilayo I.; Clarke, Michael F.; Greene, Geoffrey L.; Liu, Huiping // Nature Communications;Jan2013, Vol. 4 Issue 1, p1393 

    Chemotherapy resistance frequently drives tumour progression. However, the underlying molecular mechanisms are poorly characterized. Epithelial-to-mesenchymal transition has been shown to correlate with therapy resistance, but the functional link and signalling pathways remain to be elucidated....

  • The Epithelial-to-Mesenchymal Transition and Cancer Stem Cells: A Coalition Against Cancer Therapies. Brett Hollier; Kurt Evans; Sendurai Mani // Journal of Mammary Gland Biology & Neoplasia;Mar2009, Vol. 14 Issue 1, p29 

    Abstract  During cancer progression, some cells within the primary tumor may reactivate a latent embryonic program known as epithelial-to-mesenchymal transition (EMT). Through EMT, transformed epithelial cells can acquire the mesenchymal traits that seem to facilitate metastasis. Indeed,...

  • Twist-1 Up-Regulation in Carcinoma Correlates to Poor Survival. Wushou, Alimujiang; Jing Hou; Ya-Jun Zhao; Zhi-Ming Shao // International Journal of Molecular Sciences;2014, Vol. 15 Issue 12, p21621 

    Epithelial-to-mesenchymal transition (EMT) facilitates tumor metastasis. Twist is a basic helix-loop-helix protein that modulates many target genes through E-box-responsive elements. There are two twist-like proteins, Twist-1 and Twist-2, sharing high structural homology in mammals. Twist-1 was...

  • Aberrant Splicing in Cancer: Mediators of Malignant Progression through an Imperfect Splice Program Shift. Luz, Felipe andrés Cordero; Brígido, Paula Cristina; Moraes, alberto Silva; Silva, Marcelo José Barbosa // Oncology;Jan2017, Vol. 92 Issue 1, p3 

    Although the efforts to understand the genetic basis of cancer allowed advances in diagnosis and therapy, little is known about other molecular bases. Splicing is a key event in gene expression, controlling the excision of introns decoded inside genes and being responsible for 80% of the...

  • Cancer-associated fibroblasts as abettors of tumor progression at the crossroads of EMT and therapy resistance. Eleonora Fiori, Micol; Di Franco, Simone; Villanova, Lidia; Bianca, Paola; Stassi, Giorgio; De Maria, Ruggero // Molecular Cancer;3/30/2019, Vol. 18 Issue 1, p1 

    In the last decades, the role of the microenvironment in tumor progression and therapeutic outcome has gained increasing attention. Cancer-associated fibroblasts (CAFs) have emerged as key players among stromal cells, owing to their abundance in most solid tumors and their diverse...

  • Tumor-Associated Mast Cells in Thyroid Cancer. Visciano, Carla; Prevete, Nella; Liotti, Federica; Marone, Gianni // International Journal of Endocrinology;8/26/2015, Vol. 2015, p1 

    There is compelling evidence that the tumor microenvironment plays a major role in mediating aggressive features of cancer cells, including invasive capacity and resistance to conventional and novel therapies. Among the different cell populations that infiltrate cancer stroma, mast cells (MCs)...

  • Vascular Endothelial Growth Factor Receptor 1, a Therapeutic Target in Cancer, Inflammation and Other Disorders. Yan Wu; Zhenping Zhu // Current Medicinal Chemistry;Aug2009, Vol. 16 Issue 22, p2890 

    The vascular endothelial growth factor (VEGF)/VEGF receptor pathways are essential for the regulation of angiogenesis during embryonic development and tumor progression. VEGF receptor 1 (VEGFR-1) has been shown to promote tumor growth and metastasis through the regulation of multiple biological...

  • Morusin inhibits human cervical cancer stem cell growth and migration through attenuation of NF-κB activity and apoptosis induction. Wang, Li; Guo, Huijie; Yang, Liuqi; Dong, Lihua; Lin, Caiyu; Zhang, Jie; Lin, Ping; Wang, Xiujie // Molecular & Cellular Biochemistry;Jul2013, Vol. 379 Issue 1/2, p7 

    Cancer stem cells (CSCs) are believed to be responsible for tumor metastasis, recurrence, and high mortality of cancer patients due to their high tumorigenicity resistance to chemo-radiotherapy. Morusin possesses anti-cancer activity through attenuation of NF-κB activity, which is...

  • Sema3E/Plexin-D1 Mediated Epithelial-to-Mesenchymal Transition in Ovarian Endometrioid Cancer. Chun-Hsien Tseng; Murray, Karl D.; Mu-Fan Jou; Su-Ming Hsu; Hwai-Jong Cheng; Pei-Hsin Huang // PLoS ONE;2011, Vol. 6 Issue 4, p1 

    Cancer cells often employ developmental cues for advantageous growth and metastasis. Here, we report that an axon guidance molecule, Sema3E, is highly expressed in human high-grade ovarian endometrioid carcinoma, but not low-grade or other ovarian epithelial tumors, and facilitates tumor...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics